Development of Oxytolerant Salmonella typhimurium Using Radiation Mutation Technology (RMT) for Cancer Therapy

A critical limitation of Salmonella typhimurium (S. typhimurium) as an anti-cancer agent is the loss of their invasive or replicative activities, which results in no or less delivery of anti-cancer agents inside cancer cells in cancer therapy. Here we developed an oxytolerant attenuated Salmonella s...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Shuang, Jung, Jong-Hyun, Lin, Shun-Mei, Jang, A-Yeung, Zhi, Yong, Bum Ahn, Ki, Ji, Hyun-Jung, Hyang Lim, Jae, Guo, Huichen, Choy, Hyon E., Lim, Sangyong, Seo, Ho Seong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048768/
https://www.ncbi.nlm.nih.gov/pubmed/32111878
http://dx.doi.org/10.1038/s41598-020-60396-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048768/
https://www.ncbi.nlm.nih.gov/pubmed/32111878
http://dx.doi.org/10.1038/s41598-020-60396-6

Ejemplares similares